Def Leppard Guitarist Says His Hodgkin's Has Returned

During a conversation with the West Palm Beach, Fla. rock station 98.7 The Gater, Def Leppard guitarist Vivian Campbell made the announcement that his cancer appears to have returned.

"[My Hodgkin’s lymphoma] seems to be, kind of, coming back again," he said. "But I’m not concerned about it. I mean, it’s just a process. I mean, it always was a little bit touch-and-go. But, you know, it’s just a process to get through.

"I mean, like I said, it’s absolutely nothing I’m concerned about, but it’s something I need to start the process, I need to get a handle on, so that I am free and clear to tour this summer. So, all good. You know what I mean?”

Assuming Campbell underwent standard treatment for his Hodgkin's, this might be slightly more concerning than he is letting on, since about ten percent of Hodgkin's patients do not respond to frontline therapy and are much more difficult to treat than the other 90 percent. Fortunately, new agents have been developed, such as Adcetris, to help patients whose Hodgkin's have recurred or relapsed.

In June of 2013, Campbell announced that he had been diagnosed with Hodgkin's lymphoma. He had begun treatment by then and five months later, in November of that year, Campbell announced that he was in remission from Hodgkin's.

Source: Ultimateclassicrock.com

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap